The effect of intraoperative remifentanil and sufentanil TCI on postoperative pain and postoperative opioid consumption in breast cancer surgery: A randomized controlled study
- Conditions
- Neoplasms
- Registration Number
- KCT0009226
- Lead Sponsor
- Chung-Ang University Gwangmyeong Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 86
Adult female patient with American Society of Anesthesiologists physical status level 1-2 scheduled for breast-conserving surgery under general anesthesia
- Under 18 years of age or over 70 years of age
- ASA 3 or higher
- BMI 35 or higher
- Pregnant and lactating women
- Patients with serious cardiovascular, liver, kidney, and hematological abnormalities
- Patients with uncontrolled respiratory disease and moderate to severe pulmonary dysfunction
- Those taking opioids, anticonvulsants, or antidepressants
- Those with a history of hypersensitivity or serious side effects to drugs related to this study (opioids, acetaminophen, tramadol)
- During the surgical procedure, the scope of surgery is reduced to a tumor resection or expanded to a total mastectomy.
- Those who refused to participate in this study
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Opioid consumption during 24 hours after surgery
- Secondary Outcome Measures
Name Time Method Pain score (11-point NRS) at 30 minutes, 6 hours, 24 hours, and 48 hours after surgery, presence of nausea and vomiting, number of antiemetic drugs administered after surgery